When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Last reviewed: 23 Apr 2025
Last updated: 16 Apr 2024

Summary

Definition

History and exam

Key diagnostic factors

  • digoxin exposure
  • gastrointestinal symptoms
  • central nervous system symptoms
  • visual symptoms

Other diagnostic factors

  • suicidality
  • cardiovascular symptoms

Risk factors

  • age >55 years
  • decreased renal clearance
  • hyperkalemia (>5.0 mEq/L)
  • hypokalemia (<3.0 to 3.5 mEq/L)
  • concomitant use of specific drugs
  • hypomagnesemia
  • hypercalcemia
  • hypothyroidism

Diagnostic tests

1st tests to order

  • ECG
  • digoxin serum concentration
  • serum potassium level
  • serum magnesium level
  • serum creatinine and BUN

Treatment algorithm

Contributors

Authors

Scott Phillips, MD

Associate Clinical Professor of Medicine

Department of Clinical Pharmacology and Toxicology

University of Colorado

Denver

CO

Associate Medical Director

Washington Poison Center

Seattle

WA

Disclosures

SP declares that he has no competing interests.

Acknowledgements

Dr Scott Phillips would like to gratefully acknowledge Dr Oladapo A. Odujube and Dr Robert S. Hoffman, previous contributors to this topic.

Disclosures

OAO and RSH declare that they have no competing interests.

Peer reviewers

Edward W. Boyer, MD

University of Massachusetts Medical School

Worcester

MA

Disclosures

EWB declares that he has no competing interests.

Ruben Thanacoody, MD, FRCP(Edin)

Consultant Physician and Clinical Toxicologist

National Poisons Information Service (Newcastle)

Newcastle-upon-Tyne

UK

Disclosures

RT declares that he has no competing interests.

References

Our in-house evidence and editorial teams collaborate with international expert contributors and peer reviewers to ensure that we provide access to the most clinically relevant information possible.

Key articles

Gheorghiade M, van Veldhuisen DJ, Colucci WS. Contemporary use of digoxin in the management of cardiovascular disorders. Circulation. 2006 May 30;113(21):2556-64. Abstract

Smith TW, Haber E, Yeatman L, et al. Reversal of advanced digoxin intoxication with Fab fragments of digoxin-specific antibodies. N Engl J Med. 1976 Apr 8;294(15):797-800. Abstract

Smith TW, Butler VP Jr, Haber E, et al. Treatment of life-threatening digitalis intoxication with digoxin-specific Fab antibody fragments: experience in 26 cases. N Engl J Med. 1982 Nov 25;307(22):1357-62. Abstract

Bismuth C, Gaultier M, Conso F, et al. Hyperkalemia in acute digitalis poisoning: prognostic significance and therapeutic implications. Clin Toxicol. 1973;6(2):153-62. Abstract

Taboulet P, Baud FJ, Bismuth C, et al. Acute digitalis intoxication--is pacing still appropriate? J Toxicol Clin Toxicol. 1993;31(2):261-73. Abstract

Reference articles

A full list of sources referenced in this topic is available here.

Use of this content is subject to our disclaimer